The Day In Review: Three-Peat Loss For Biotech In 2005

January 5, 2005 -- Biotech lost another 1.84% on Wednesday, while broader markets also showed losses, though smaller ones. The Centient Biotech 200™ dropped 64.17 points to 3430.94. On the other hand, during 2004 biotech had a very solid year (see Winners and Losers in Biotech during 2004). We look at Keryx, whose drug passed a test and has a big market, Sequenom's rising sales, the positive news for Immunomedics, and Sagamo's tapping into Pfizer extra-large pockets.

Back to news